Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHowden Joinery Regulatory News (HWDN)

Share Price Information for Howden Joinery (HWDN)

Share Price is delayed by 15 minutes
Get Live Data
820.50    -5.50 (-0.67%)
Bid:
820.00
Ask:
820.50
Spread: 0.50 (0.061%)
Market Cap: £4.52b
HWDN Live PriceLast checked at - London Stock Exchange

Intraday Howden Joinery Share Chart

Howdens CFO Succession

16 Oct 2020 07:00

RNS Number : 2665C
Howden Joinery Group PLC
16 October 2020
 

 

16 October 2020

 

 

Howden Joinery Group Plc

("Howdens")

 

CFO SUCCESSION

Howden Joinery Group Plc today announces that Mark Robson will be moving on from his role as Deputy Chief Executive and Chief Financial Officer (DCEO & CFO) on 26th December 2020, in order to take on a new challenge outside of the Group. He will be succeeded as Chief Financial Officer (CFO) by Paul Hayes, previously CFO of Consort Medical Plc. Paul will join Howdens on 2nd November 2020 and will become an executive director and member of Howdens' Board on 27th December 2020. Having ensured smooth transition through the CEO succession from Matthew Ingle to Andrew Livingston, the Board has reviewed the Group's executive structure and concluded it will revert to a standard structure with CEO and CFO on the Board.

 

Mark Robson joined the Group Board as CFO in April 2005 and was appointed Deputy CEO in May 2014 in addition to his role as CFO. In his early years as CFO he was integral in the restructuring and refinancing of the Group, strengthening its balance sheet whilst ensuring that there was sufficient capital for the Howdens business to grow. During his tenure, the number of Howdens depots has grown from 342 to 759, with turnover increasing from £618m to £1.6bn. During the same period the Group share price has increased from £0.80 to £6.731.

 

Paul Hayes was CFO of Consort Medical Plc, the developer and manufacturer of drugs and premium drug delivery devices, from 2017 until its acquisition by Recipharm AB in February 2020. He has extensive experience in senior finance roles at a number of UK and US listed companies including Vitec Group Plc, Signet Jewelers, RHM Plc and Smiths Group Plc. He is a chartered accountant and qualified with Ernst & Young. 

Richard Pennycook, Chairman of Howdens, commented: "Mark has played a pivotal role, over many years, in building Howdens into the strong, sizeable and successful business it is today. His careful, thoughtful and prudent management of the company's finances has been a key element of our ability to weather the storm of the Covid-19 pandemic. The Board gives heartfelt thanks for his service and he should be proud of his many achievements. On behalf of the Board, I welcome Paul to the Group."

 

Andrew Livingston, CEO said: "Mark has made a very significant contribution to the success of Howdens over the last 15 years and I am especially grateful for his advice, guidance and support since I first joined the business in 2018. I have enjoyed working with him enormously and, together with the whole team at Howdens, wish him the very best for the future.

 

"Paul Hayes comes to the business with a first class record of achievement in consumer and vertically integrated businesses and will, I'm sure, be a great fit with Howdens. I very much look forward to working with him."

 

Paul Hayes will be paid in line with Howden's remuneration policy as approved by shareholders in May 2019. He has no other listed company appointments and has not been a director of any listed company in the previous five years, which would need to be disclosed under LR 9.6.13(1) other than those disclosed above.

 

There is no further information required to be disclosed pursuant to paragraph 9.6.13R of the Listing Rules in respect of Paul Hayes.

 

This announcement is made in accordance with Listing Rules 9.6.11R and 9.6.13 R.

 

 1Depot, turnover and share price figures are as at 31 December 2005 and 31 December 2019.

 

 Enquiries

 Investors/analysts:

 Guy Stainer

 Head of Investor Relations + 44 (0) 20 7535 1164/+44 (0) 7739 778187

 

 Media:

 Citigate

 Simon Rigby/Nick Hayns + 44 (0) 20 3926 8503

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAMABPTMTBBBTM
Date   Source Headline
1st Jul 202612:05 pmRNSTotal Voting Rights
29th Jun 20264:52 pmRNSTransaction in Own Shares
24th Jun 20264:02 pmRNSHolding(s) in Company
24th Jun 202612:56 pmRNSHolding(s) in Company
23rd Jun 202610:30 amRNSCompletion of the acquisition of DIY Kitchens
22nd Jun 20263:49 pmRNSAdmission of New Ordinary Shares
22nd Jun 20269:14 amRNSTransaction in Own Shares
15th Jun 20265:08 pmRNSDirector/PDMR Shareholding
12th Jun 20265:22 pmRNSTransaction in Own Shares
8th Jun 20261:28 pmRNSTransaction in Own Shares
4th Jun 20263:38 pmRNSDirector/PDMR Shareholding
3rd Jun 20268:00 amRNSShare Buyback Programme
3rd Jun 20267:00 amRNSHowdens agrees to acquire DIY Kitchens
1st Jun 202611:37 amRNSTotal Voting Rights
27th May 20265:22 pmRNSDirector/PDMR Shareholding
14th May 20265:42 pmRNSDirector/PDMR Shareholding
14th May 202612:48 pmRNSHolding(s) in Company
7th May 20261:10 pmRNSResult of AGM
7th May 20268:00 amRNSAGM Statement
1st May 20269:00 amRNSTotal Voting Rights
28th Apr 20267:00 amRNSTrading Update
21st Apr 20263:28 pmRNSDirector/PDMR Shareholding
21st Apr 20267:00 amRNSTransfer of Treasury Shares
15th Apr 20266:04 pmRNSHolding(s) in Company
15th Apr 20266:00 pmRNSHolding(s) in Company
15th Apr 20269:00 amRNSDirector/PDMR Shareholding
10th Apr 20265:00 pmRNSDirector/PDMR Shareholding
9th Apr 20262:36 pmRNSDirector/PDMR Shareholding
9th Apr 20269:00 amRNSHolding(s) in Company
7th Apr 20264:53 pmRNSTransfer of Treasury Shares
1st Apr 20269:00 amRNSTotal Voting Rights
30th Mar 20269:00 amRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSAnnual Report and Accounts and Notice of AGM
13th Mar 20265:51 pmRNSSIP PDMR Notification
2nd Mar 20269:00 amRNSTotal Voting Rights
26th Feb 20267:00 amRNS2025 Full Year Results
16th Feb 20269:00 amRNSSIP PDMR Notification
2nd Feb 20269:00 amRNSBlock Listing Interim Review
2nd Feb 20269:00 amRNSTotal Voting Rights
21st Jan 202612:35 pmRNSSIP PDMR Notification (replacement)
20th Jan 20263:00 pmRNSSIP PDMR Notification
2nd Jan 20269:00 amRNSTotal Voting Rights
17th Dec 20252:33 pmRNSDirector/PDMR Shareholding
15th Dec 20251:00 pmRNSChange of Registrar
8th Dec 20259:59 amRNSSIP PDMR Notification
1st Dec 20259:00 amRNSTotal Voting Rights
25th Nov 20255:20 pmRNSDirector/PDMR Shareholding
24th Nov 20256:14 pmRNSDirector/PDMR Shareholding
20th Nov 20255:17 pmRNSTransaction in Own Shares
20th Nov 20251:50 pmRNSSIP PDMR Notification

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.